Bär & Karrer Advises dsm-firmenich on the Sale of its Stake in the Feed Enzymes Alliance

On 11 February 2025, dsm-firmenich, innovators in nutrition, health and beauty, agreed to sell its stake in the Feed Enzymes Alliance to its equal partner Novonesis, a global leader in biosolutions, for EUR 1.5 billion.

The dsm-firmenich activities to be sold under this transaction to Novonesis represented in 2024 approximately EUR 300 million in total annual net sales. Novonesis will continue a long-term commercial relationship with dsm-firmenich's Animal Nutrition & Health business, for the re-sale of its feed enzymes through the Animal Nutrition & Health world-class premix network.

This transaction is expected to be completed in the course of 2025, subject to customary conditions and regulatory approvals.

Bär & Karrer acts as Swiss legal advisor to dsm-firmenich. The team includes Urs Kägi, Michael Bänziger and Florian Schweighofer (all M&A/Corporate & Commercial), Susanne Schreiber and Donjeta Beka (both Tax) and Julia Eiholzer (Notarial Services).